Medicinal Product Shortages - update - 1 February 2023

Notice type: Advisory

Date: 01/02/2023


Further Information:

Note regarding shortage listing on the HPRA webpage:

For many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers. Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. The published information in relation to medicine shortages is regularly updated to keep patients and healthcare professionals informed of current and resolved shortages.



The following shortages have been resolved and supply has resumed to the Irish market:

  • Amoxicilin 500mg Capsules - PA0126/282/002
  • Azactam 1g Powder for Solution for Injection or Infusion - PA0002/052/002
  • Brolene 0.1% w/v Eye Drops Solution - PA0126/357/001
  • Brufen 400mg Film Coated Tablets - PA2010/002/001
  • Epanutin 100mg Capsules - PA23055/003/003
  • Epanutin 300mg Capsules - PA23055/003/004
  • Flucloxacillin 250mg/5ml Oral Solution – PA0298/017/004
  • Galfer 305mg Hard Capsules – PA0126/314/001
  • Genotropin MiniQuick 0.6mg Powder and Solvent for Solution for Injection -PA0822/128/005
  • Ibandronic Acid Mylan 150mg Film Coated Tablets - PA0577/111/001
  • Lercanidipine Clonmel 20mg Film Coated Tablets - PA0126/187/002
  • Mysimba 8mg/90mg Prolonged Release Tablets – EU/1/14/988/001
  • Nortem 20mg Tablets – PA1986/085/002
  • Praxilene 100mg Capsules - PA2286/003/001
  • Pregabalin Sandoz 75mg Capsules - EU/1/15/1011/021
  • Rowalief 500mg Film Coated Tablets (300 pack) – PA0074/065/001
  • Sandostatin 500mcg/1ml, Solution for Injection/Infusion - PA0896/028/003
  • Vimpat 10mg/ml Solution for Infusion - EU/1/08/470/016
  • Xylocaine 2% with Adrenaline (Epinephrine) (1:200,000) Solution for Injection - PA1691/027/001

The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Abstral 100mcg Sublingual Tablets – PA2288/004/002
  • Allopurinol Teva 300mg Tablets – PA0749/099/003
  • Aminophylline Hydrate 25mg/ml Solution for Injection - PA0073/099/001
  • Braftovi 50mg Capsules – EU/1/18/1314/001
  • Calvepen 333mg Tablets - PA0126/137/001
  • Campto 20mg/mL Concentrate for Solution for Infusion (2ml vial) -PA0822/212/001
  • Ciplox 500mg Film Coated Tablets - PA2315/100/001
  • Clonocid 250mg Film Coated Tablets – PA0126/136/001
  • Clorom 500mg Tablets – PA0711/061/002
  • Fucidin 20mg/g cream – PA0046/004/012
  • Gabin 100mg capsules – PA1445/020/001
  • Glytrin 400mcg Per Metered Dose Sublingual Spray - PA22906/002/001
  • Marcain 0.25% w/v with Adrenaline (Epinephrine, 5 micrograms per ml) (1:200,000) Solution for Injection – PA1691/025/001
  • Neurostil 100mg Capsules – PA0749/164/001
  • Night Nurse Cold Remedy Oral Solution – PA0678/014/001
  • Olmesartan medoxomil 20mg Film Coated Tablets – PA0577/214/002
  • Otrivine Congestion Relief Menthol 0.1% w/v Nasal Spray - PA0678/120/002
  • Otrivine Congestion Relief 0.1% w/v Nasal Spray, Solution - PA0678/120/005
  • Phenergan 25mg Film Coated Tablets – PA23180/011/002
  • Robitussin Chesty Cough 100mg/5ml Oral Solution - PA0678/153/001
  • Robitussin Plus Oral Solution - PA0678/154/001
  • Zanidip 10mg Film Coated Tablets - PA0812/001/001
  • Zanidip 20mg Film Coated Tablets - PA0812/001/002



Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

« Back